ATC Group: A10BD13 Metformin and alogliptin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BD13 in the ATC hierarchy

Level	Code	Title
1	A	Alimentary tract and metabolism
2	A10	Drugs used in diabetes
3	A10B	Blood glucose lowering drugs, excl. insulins
4	A10BD	Combinations of oral blood glucose lowering drugs
5	A10BD13	Metformin and alogliptin

Active ingredients in A10BD13

Active Ingredient	Description
Metformin and Alogliptin

Related product monographs

Title	Information Source	Document Type
VIPDOMET Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicines in this ATC group

United States (US)

(combination) KAZANO

Australia (AU)

(combination) NESINA MET

Austria (AT)

(combination) VIPDOMET

Brazil (BR)

(combination) NESINA MET

Canada (CA)

(combination) KAZANO

Croatia (HR)

(combination) VIPDOMET

Ecuador (EC)

(combination) FEBUMET

Estonia (EE)

(combination) VIPDOMET

Finland (FI)

(combination) VIPDOMET

France (FR)

(combination) VIPDOMET

Hong Kong (HK)

(combination) NESINA MET

Ireland (IE)

(combination) VIPDOMET

Italy (IT)

(combination) VIPDOMET

Japan (JP)

(combination) INISYNC

Lithuania (LT)

(combination) VIPDOMET

Poland (PL)

(combination) VIPDOMET

Spain (ES)

(combination) VIPDOMET

United Kingdom (UK)

(combination) VIPDOMET

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Go to ATC index